<div class="article">
	<h3>Business Brief -- Immunex Corp.:
   Investor Richard C. Hedreen
   Increases Holding to 7.91%</h3>
	<div class="article-info">
		<ul>
			<li>Author: Author Unknown</li>
			<li>Date: 06/12/90</li>
		</ul>
	</div>
	<p class="article-leader">Richard C. Hedreen, president of R.C. Hedreen Co.,
Seattle, said he raised his stake in Immunex Corp. to the
equivalent of 7.91% of the common shares outstanding.
   In a filing with the Securities and Exchange Commission,
Mr. Hedreen said that as of June 6 he controlled 633,789
Immunex common shares, assuming the conversion of debentures
and the exercise of warrants. His Immunex holdings include
securities held by immediate family members, the filing said.</p>
	<div class="article-body"><p>Last December, Mr. Hedreen said he controlled the
equivalent of a 6.39% stake in Immunex.</p>
<p>In the filing, Mr. Hedreen said he acquired his Immunex
holdings solely for investment purposes.</p>
<p>Seattle-based Immunex, a biotechnology concern, declined
to comment.</p>
<p></p></div>
</div>
